| Literature DB >> 24698848 |
Yasuhiro Nishiyama1, Hiroaki Taguchi1, Mariko Hara1, Stephanie A Planque1, Yukie Mitsuda1, Sudhir Paul2.
Abstract
Catalytic antibodies (catabodies) that degrade target antigens rapidly are rare. We describe the metal-dependence of catabody construct 2E6, an engineered heterodimer of immunoglobulin light chain variable domains that hydrolyzes amyloid β peptides (Aβ) specifically. In addition to the electrophilic phosphonate inhibitor of serine proteases, the metal chelators ethylenediaminetetraacetic acid (EDTA) and 1,10-phenanthroline completely inhibited the hydrolysis of Aβ by catabody 2E6. Formation of catabody-electrophilic phosphonate inhibitor adducts was unaffected by EDTA, suggesting that the metal exerts a favorable effect on a catalytic step after the initial catabody nucleophilic attack on Aβ. The EDTA inactivated catabody failed to disaggregate fibrillar Aβ, indicating the functional importance of the Aβ hydrolytic activity. Treating the EDTA-inactivated catabody with Zn(2+) or Co(2+) restored the Aβ hydrolytic activity, and Zn(2+)-induced catabody conformational transitions were evident by fluorescence emission spectroscopy. The studies reveal the absolute catabody dependence on a metal cofactor.Entities:
Keywords: Alzheimer disease; Amyloid β clearance; Catalytic antibody light chain; Metal activation
Mesh:
Substances:
Year: 2014 PMID: 24698848 PMCID: PMC4512298 DOI: 10.1016/j.jbiotec.2014.03.026
Source DB: PubMed Journal: J Biotechnol ISSN: 0168-1656 Impact factor: 3.307